Two Sigma Advisers’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,181
| Closed | -$128K | – | 2855 |
|
|
2022
Q4 | $128K | Sell |
11,181
-7,500
| -40% | -$86K | ﹤0.01% | 2264 |
|
|
2022
Q3 | $70K | Sell |
18,681
-300
| -2% | -$1.12K | ﹤0.01% | 2349 |
|
|
2022
Q2 | $113K | Sell |
18,981
-4,200
| -18% | -$25K | ﹤0.01% | 2378 |
|
|
2022
Q1 | $147K | Sell |
23,181
-2,500
| -10% | -$15.9K | ﹤0.01% | 2437 |
|
|
2021
Q4 | $100K | Sell |
25,681
-6,800
| -21% | -$26.5K | ﹤0.01% | 2406 |
|
|
2021
Q3 | $157K | Sell |
32,481
-9,685
| -23% | -$46.8K | ﹤0.01% | 2286 |
|
|
2021
Q2 | $269K | Sell |
42,166
-116,079
| -73% | -$741K | ﹤0.01% | 2176 |
|
|
2021
Q1 | $994K | Sell |
158,245
-61,865
| -28% | -$389K | ﹤0.01% | 1655 |
|
|
2020
Q4 | $1.52M | Buy |
+220,110
| New | +$1.52M | ﹤0.01% | 1392 |
|
|
2017
Q3 | – | Sell |
-1,881
| Closed | -$18K | – | 2449 |
|
|
2017
Q2 | $18K | Buy |
+1,881
| New | +$18K | ﹤0.01% | 2228 |
|
|
2016
Q2 | – | Sell |
-1,284
| Closed | -$85K | – | 2279 |
|
|
2016
Q1 | $85K | Buy |
+1,284
| New | +$85K | ﹤0.01% | 1959 |
|
|
2015
Q4 | – | Sell |
-5,405
| Closed | -$402K | – | 2097 |
|
|
2015
Q3 | $402K | Sell |
5,405
-7,763
| -59% | -$577K | ﹤0.01% | 1376 |
|
|
2015
Q2 | $1.28M | Sell |
13,168
-10,883
| -45% | -$1.06M | 0.01% | 1010 |
|
|
2015
Q1 | $2.25M | Buy |
24,051
+5,755
| +31% | +$538K | 0.02% | 718 |
|
|
2014
Q4 | $1.63M | Buy |
18,296
+11,518
| +170% | +$1.02M | 0.01% | 847 |
|
|
2014
Q3 | $468K | Buy |
6,778
+3,978
| +142% | +$275K | ﹤0.01% | 1235 |
|
|
2014
Q2 | $161K | Buy |
+2,800
| New | +$161K | ﹤0.01% | 1776 |
|